Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Comment by OptGreenon Feb 12, 2019 3:13pm
90 Views
Post# 29354538

RE:RE:RE:RE:Not Acceptable

RE:RE:RE:RE:Not AcceptableDefinately part of it Mrd, but yield more positives than not with lessons learned....although not an acceptable result for level of quality of product, business model and expectations, this is company's first post legal rec report.

Nothing has changed in the ability of and/ or potential for FIRE to meet and exceed estimates and expectations, in fact it may be an asset as I don't think this team will let this level of preformance to repeat it self and improve in areas where required...this is still a good report, just not as great as we were wanting to see but they need to turn things around starting this quarter,as there is a limit to tolerance in business, JMHO...Opt

Mrderalick wrote: Is this our issue with less revenue than when we did numbers?

The company may have been overly optimistic in valuing its cannabis plants before sale, however. Supreme said the fair value changes on the growth of its biological assets came to C$10 million, but the realized fair value changes on inventory sold or impaired was C$6 million. Combining the C$6 million with the C$4 million of production costs exceeds the C$7.72 million revenue number.


<< Previous
Bullboard Posts
Next >>